ArticleOncoimmunology2021

Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients.

Glenn F Van Wigcheren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.